AKSO HEALTH GR. (SPADR)/3 (F:8HX) — Market Cap & Net Worth
Market Cap & Net Worth: AKSO HEALTH GR. (SPADR)/3 (8HX)
AKSO HEALTH GR. (SPADR)/3 (F:8HX) has a market capitalization of $1.60 Billion (€1.37 Billion) as of August 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #6845 globally and #995 in its home market, demonstrating a -16.06% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AKSO HEALTH GR. (SPADR)/3's stock price €1.62 by its total outstanding shares 854043910 (854.04 Million). See AKSO HEALTH GR. (SPADR)/3 (8HX) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
AKSO HEALTH GR. (SPADR)/3 Market Cap History: 2018 to 2026
AKSO HEALTH GR. (SPADR)/3's market capitalization history from 2018 to 2026. Data shows change from $6.17 Billion to $1.31 Billion (-18.78% CAGR).
AKSO HEALTH GR. (SPADR)/3 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AKSO HEALTH GR. (SPADR)/3's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
79.05x
AKSO HEALTH GR. (SPADR)/3's market cap is 79.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $275.58 Million | $6.00 Million | -$16.85 Million | 45.93x | N/A |
| 2023 | $614.06 Million | $13.18 Million | -$1.36 Million | 46.58x | N/A |
| 2024 | $1.03 Billion | $2.41 Million | -$9.46 Million | 425.96x | N/A |
| 2025 | $1.17 Billion | $14.78 Million | -$134.98 Million | 79.05x | N/A |
Competitor Companies of 8HX by Market Capitalization
Companies near AKSO HEALTH GR. (SPADR)/3 in the global market cap rankings as of August 1, 2026.
Key companies related to AKSO HEALTH GR. (SPADR)/3 by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #272 globally with a market cap of $94.62 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #525 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #624 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1092 globally with a market cap of $24.01 Billion USD ( AU$33.94 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #272 | McKesson Corporation | NYSE:MCK | $94.62 Billion | $856.19 |
| #525 | Cencora Inc. | NYSE:COR | $50.53 Billion | $311.34 |
| #624 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $230.03 |
| #1092 | Sigma Healthcare Ltd | AU:SIG | $24.01 Billion | AU$2.94 |
AKSO HEALTH GR. (SPADR)/3 Historical Marketcap From 2018 to 2026
Between 2018 and today, AKSO HEALTH GR. (SPADR)/3's market cap moved from $6.17 Billion to $ 1.31 Billion, with a yearly change of -18.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.31 Billion | +11.97% |
| 2025 | €1.17 Billion | +13.59% |
| 2024 | €1.03 Billion | +67.48% |
| 2023 | €614.06 Million | +122.83% |
| 2022 | €275.58 Million | -83.76% |
| 2021 | €1.70 Billion | -9.57% |
| 2020 | €1.88 Billion | -26.27% |
| 2019 | €2.55 Billion | -58.74% |
| 2018 | €6.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of AKSO HEALTH GR. (SPADR)/3 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.60 Billion USD |
| MoneyControl | $1.60 Billion USD |
| MarketWatch | $1.60 Billion USD |
| marketcap.company | $1.60 Billion USD |
| Reuters | $1.60 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AKSO HEALTH GR. (SPADR)/3
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more